Modular Medical, Inc. (MODD)
3.68
+0.26
(+7.60%)
USD |
NASDAQ |
Sep 04, 16:00
3.48
-0.20
(-5.43%)
After-Hours: 20:00
Modular Medical Research and Development Expense (Quarterly) : 3.87M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.87M |
| March 31, 2026 | 3.40M |
| December 31, 2025 | 4.975M |
| September 30, 2025 | 5.202M |
| June 30, 2025 | 4.724M |
| March 31, 2025 | 3.611M |
| December 31, 2024 | 3.572M |
| September 30, 2024 | 3.442M |
| June 30, 2024 | 3.205M |
| March 31, 2024 | 3.676M |
| December 31, 2023 | 3.619M |
| September 30, 2023 | 2.98M |
| June 30, 2023 | 2.604M |
| March 31, 2023 | 2.258M |
| December 31, 2022 | 2.196M |
| September 30, 2022 | 2.385M |
| June 30, 2022 | 2.222M |
| March 31, 2022 | 1.986M |
| December 31, 2021 | 1.849M |
| September 30, 2021 | 2.105M |
| June 30, 2021 | 1.788M |
| March 31, 2021 | 0.9332M |
| December 31, 2020 | 1.087M |
| September 30, 2020 | 1.093M |
| June 30, 2020 | 0.9708M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.089M |
| December 31, 2019 | 0.608M |
| September 30, 2019 | 0.6332M |
| June 30, 2019 | 0.7038M |
| March 31, 2019 | 0.8742M |
| December 31, 2018 | 0.5048M |
| September 30, 2018 | 0.3676M |
| June 30, 2018 | 0.1358M |
| March 31, 2018 | 0.0738M |
| December 31, 2017 | 0.171M |
| September 30, 2017 | 0.0834M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 46.93M |
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |
| ResMed, Inc. | 105.73M |